Topical Drug Delivery Market Size, Share & Trends Analysis Report By Type (Semi-solids (Creams, Gels, Lotions), Solids (Suppositories), Liquids (Solutions), Transdermal Products), Route (Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres), Region And Segment Forecasts, 2023-2031
Topical Drug Delivery Market Size is valued at USD 208.25 billion in 2022 and is predicted to reach USD 418.70 billion by the year 2031 at a 8.1% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: The main reasons driving this market's growth are the rising rates of minor illnesses like acne and psoriasis as well as skin diseases like eczema. Transdermal delivery of biologics i...
Report ID: 2081 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Serotonin Supplement Market Size, Share & Trends Analysis Report, By Type (Standard Grade Celecoxib API, & Micronized Celecoxib API), By Application (Pharmaceutical, & Laboratory), By Region, Forecasts, 2024-2031
Serotonin Supplement Market Size was valued at USD 939.6 Mn in 2023 and is predicted to reach USD 1,355.5 Mn by 2031 at a 4.8% CAGR during the forecast period for 2024-2031. Serotonin supplement is a neurotransmitter that helps control appetite, sleep, and mood; increasing blood levels of the neurotransmitter is the major objective of serotonin supplements. Mood, sleep, and mental health issues are common reasons people take these supplements....
Report ID: 2477 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Gemigliptin Market Size, Share & Trends Analysis Report By Type of Drug (Gemigliptin Monotherapy & Gemigliptin Combination Therapy), By Dosage Form (Gemigliptin Tablets & Gemigliptin Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, & Online Pharmacies), By End-User, By Application, By Patient Demographics, Region And Segment Forecasts, 2023-2031
The Gemigliptin Market Size is valued at USD 1.66 billion in 2022 and is predicted to reach USD 2.65 billion by the year 2031 at a 5.5% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: Gemigliptin effectiveness in glycemic control, often in combination with other antidiabetic agents, has contributed to its widespread adoption. Greater awareness among patients about the importance of glycemi...
Report ID: 2031 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Size, Share & Trends Analysis Report By Drug Class (Bronchodilators, Combination, Corticosteroids, Phosphodiesterase), By Type (Chronic Bronchitis, Emphysema), By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Size is valued at USD 19.49 Bn in 2023 and is predicted to reach USD 33.61 Bn by the year 2031 at a 7.20% CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The increasing government initiatives and investments for research and developments drive the market growth. Rising clinical trials as well as awareness for the COP...
Report ID: 2311 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 179
Chlorphenamine Maleate API Market Size, Share & Trends Analysis Report By Type (Purity?No Higher Than 98%, Purity?Higher Than 98%) by Application (Tablets, Injection), By Region, And By Segment Forecasts, 2024-2031.
Chlorphenamine Maleate API Market Size is valued at USD 70.2 Mn in 2023 and is predicted to reach USD 120.5 Mn by the year 2031 at a 7.20% CAGR during the forecast period for 2024-2031. Chlorphenamine maleate is an important active pharmaceutical ingredient (API) in the pharmaceutical industry due to its proven effectiveness and wide range of uses in treating symptoms related to different allergic responses. The Chlorphenamine maleat...
Report ID: 2463 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Gene Therapy on Cardiovascular Disease Market Size, Share & Trends Analysis Report By Type (Viral Gene Therapy, Non-Viral Gene Therapy), By Application (Heart Disease, Vascular Disease), By Region, And By Segment Forecasts, 2024-2031.
Gene Therapy on Cardiovascular Disease Market Size is predicted to grow at a 67.4% CAGR during the forecast period for 2024-2031. Gene therapy for cardiovascular disease shows promising potential but is primarily in the experimental and clinical trial stages. Achievement in this domain has the potential to result in groundbreaking therapies for conditions that presently possess restricted therapeutic alternatives. One approach to gene therapy ...
Report ID: 2451 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 180
Microbiome Manufacturing Market Size, Share & Trends Analysis Report By Type of Product Manufactured (API and FDF), Type of Formulation (Solid, Liquid and Others), Type of Primary Packaging Used (Blister Packs, Glass / Plastic Bottles, Pouches / Sachets and Vials), Scale of Operation (Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), By Region, And By Segment Forecasts, 2024-2031.
Microbiome Manufacturing Market Size is valued at USD 27.3 Mn in 2023 and is predicted to reach USD 84.8 Mn by the year 2031 at a 15.4% CAGR during the forecast period for 2024-2031. Microbiome manufacture integrates sophisticated biotechnological techniques with a deep comprehension of microbial ecosystems, rendering it a state-of-the-art field of advancement with extensive implications for medicine, nutrition, and general health. The microbi...
Report ID: 2458 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 180
Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Liposomes Drugs, Lipid Nanoparticle Drugs) By Application (Hospital, Retail Pharmacy, Other), By Region, And By Segment Forecasts, 2024-2031.
Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size is valued at USD 5.4 Bn in 2023 and is predicted to reach USD 10.8 Bn by the year 2031 at a 9.3% CAGR during the forecast period for 2024-2031 Both liposomal and lipid nanoparticle systems are notable advancements in drug delivery technology, specifically for delivering therapeutic compounds that are challenging to administer due to stability or toxicity concerns. Their progres...
Report ID: 2459 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 179
Levonorgestrel API Market Size, Share & Trends Analysis Report, By Type (Short-Acting Contraceptive API and Long-Acting Contraceptive API), By Application (Levonorgestrel Tablet, Mixture Products, and, Hormone-releasing IUD), By Region, Forecasts, 2024-2031
Levonorgestrel API Market Size was valued at USD 52.01 Mn in 2023 and is predicted to reach USD 71.37 Mn by 2031 at a 4.13% CAGR during the forecast period for 2024-2031. Levonorgestrel is a medicine that is mostly prescribed for the purpose of preventing pregnancy. There are many ways to actively use this hormone drug to control birth. If all other methods of preventing pregnancy have been exhausted, an emergency contraceptive may be utilized...
Report ID: 2460 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 179
Adrenocortical Hormones API Market Size, Share & Trends Analysis Report By Type (Dexamethasone Series, Betamethasone Series, Hydrocortisone Series & Others), By Application (Injectable Drugs, Oral Drugs, For External Use Drugs, Inhalation Drugs), By Region, And By Segment Forecasts, 2024-2031.
Adrenocortical Hormones API Market Size is valued at USD 2.24 Bn in 2023 and is predicted to reach USD 3.55 Bn by the year 2031 at a 6.04% CAGR during the forecast period for 2024-2031. Adrenocortical hormones, also referred to as corticosteroids or adrenal cortex hormones, are steroid hormones synthesized by the adrenal cortex, which is a component of the adrenal gland. This hormone is synthesized or extracted to be used as API (Active P...
Report ID: 2453 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 180
Pharmaceuticals